Protective effects of AMP-activated protein kinase in the cardiovascular system

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 11, 2010, Pages 2604-2613

  Xu, Qiang ^a   Si, Liang Yi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AMPK; Cardiovascular system; Energy stress; Protection; Therapeutic target

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 78649712613     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01179.x     Document Type: Article

References (124)

1. Kahn BB, Alquier T, Carling D, et al AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005; 1: 15-25.
2. Kemp BE, Stapleton D, Campbell DJ, et al AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans. 2003; 31: 162-8.
3. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999; 277: E1-10.
4. Munday MR, Campbell DG, Carling D, et al Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur J Biochem. 1988; 175: 331-8.
5. Carling D, Clarke PR, Zammit VA, et al Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem. 1989; 186: 129-36.
6. Sanders MJ, Grondin PO, Hegarty BD, et al Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J. 2007; 403: 139-48.
7. Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol Rev. 2009; 89: 1025-78.
8. Sakamoto K, Goransson O, Hardie DG, et al Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Am J Physiol Endocrinol Metab. 2004; 287: E310-7.
9. Woods A, Johnstone SR, Dickerson K, et al LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol. 2003; 13: 2004-8.
10. Kemp BE, Mitchelhill KI, Stapleton D, et al Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci. 1999; 24: 22-5.
11. Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell Eur J Biochem. 1997; 246: 259-73.
12. Kelly M, Keller C, Avilucea PR, et al AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun. 2004; 320: 449-54.
13. Ruderman NB, Park H, Kaushik VK, et al AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol Scand. 2003; 178: 435-42.
14. Rutter GA, Da Silva Xavier G, Leclerc I. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J. 2003; 375: 1-16.
15. Sakamoto K, McCarthy A, Smith D, et al Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 2005; 24: 1810-20.
16. Sakamoto K, Zarrinpashneh E, Budas GR, et al Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am J Physiol Endocrinol Metab. 2006; 290: E780-8.
17. Thomson DM, Porter BB, Tall JH, et al Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice. Am J Physiol Endocrinol Metab. 2007; 292: E196-202.
18. Turnley AM, Stapleton D, Mann RJ, et al Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem. 1999; 72: 1707-16.
19. Hawley SA, Davison M, Woods A, et al Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem. 1996; 271: 27879-87.
20. Lizcano JM, Goransson O, Toth R, et al LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004; 23: 833-43.
21. Shaw RJ, Kosmatka M, Bardeesy N, et al The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A. 2004; 101: 3329-35.
22. Woods A, Vertommen D, Neumann D, et al Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J Biol Chem. 2003; 278: 28434-42.
23. Warden SM, Richardson C, O'Donnell J Jr., et al Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J. 2001; 354: 275-83.
24. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci. 2004; 29: 18-24.
25. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci. 2004; 117: 5479-87.
26. Hardie DG. New roles for the LKB1->AMPK pathway. Curr Opin Cell Biol. 2005; 17: 167-73.
27. Jansen M, Ten Klooster JP, Offerhaus GJ, et al LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev. 2009; 89: 777-98.
28. Hawley SA, Pan DA, Mustard KJ, et al Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005; 2: 9-19.
29. 2+/calmodulin-dependent protein kinase kinase alpha as Snf1-activating kinases in yeast. J Biol Chem. 2005; 280: 21804-9.
30. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem. 2005; 280: 29060-6.
31. Birnbaum MJ. Activating AMP-activated protein kinase without AMP. Mol Cell. 2005; 19: 289-90.
32. Hardie DG, Frenguelli BG. A neural protection racket: AMPK and the GABA(B) receptor. Neuron. 2007; 53: 159-62.
33. Momcilovic M, Hong SP, Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem. 2006; 281: 25336-43.
34. Xie M, Zhang D, Dyck JR, et al A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A. 2006; 103: 17378-83.
35. Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, et al TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J. 2009; 28: 677-85.
36. Lloyd SG, Wang P, Zeng H, et al Impact of low-flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart. Am J Physiol Heart Circ Physiol. 2004; 287: H351-62.
37. Rösen P, Adrian M, Feuerstein J, et al Glycolysis and glucose oxidation in the rat heart under nonrecirculating perfusion conditions. Basic Res Cardiol. 1984; 79: 307-12.
38. Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally J Physiol. 2006; 574: 95-112.
39. Hue L, Beauloye C, Marsin AS, et al Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. J Mol Cell Cardiol. 2002; 34: 1091-7.
40. Young LH, Li J, Baron SJ, et al AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med. 2005; 15: 110-8.
41. Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease. Circ Res. 2007; 100: 474-88.
42. Hawley SA, Boudeau J, Reid JL, et al Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol. 2003; 2.
43. Altarejos JY, Taniguchi M, Clanachan AS, et al Myocardial ischemia differentially regulates LKB1 and an alternate 5'-AMP-activated protein kinase kinase. J Biol Chem. 2005; 280: 183-90.
44. Nishino Y, Miura T, Miki T, et al Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res. 2004; 61: 610-9.
45. Li J, Hu X, Selvakumar P, et al Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab. 2004; 287: E834-41.
46. Horie T, Ono K, Nagao K, et al Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J Cell Physiol. 2008; 215: 733-42.
47. Shibata R, Sato K, Pimentel DR, et al Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005; 11: 1096-103.
48. Capano M, Crompton M. Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem J. 2006; 395: 57-64.
49. Kewalramani G, Puthanveetil P, Wang F, et al AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death. Cardiovasc Res. 2009; 84: 42-53.
50. Yan L, Vatner DE, Kim SJ, et al Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A. 2005; 102: 13807-12.
51. Rothermel BA, Hill JA. Myocyte autophagy in heart disease: friend or foe Autophagy. 2007; 3: 632-4.
52. Nakai A, Yamaguchi O, Takeda T, et al The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007; 13: 619-24.
53. Hamacher-Brady A, Brady NR, Logue SE, et al Response to myocardial ischemia/ reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 2007; 14: 146-57.
54. Liang J, Shao SH, Xu ZX, et al The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol. 2007; 9: 218-24.
55. Matsui Y, Takagi H, Qu X, et al Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007; 100: 914-22.
56. Viollet B, Athea Y, Mounier R, et al AMPK: Lessons from transgenic and knockout animals. Front Biosci. 2009; 14: 19-44.
57. Zarrinpashneh E, Carjaval K, Beauloye C, et al Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am J Physiol Heart Circ Physiol. 2006; 291: H2875-83.
58. Carvajal K, Zarrinpashneh E, Szarszoi O, et al Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2007; 292: H3136-47.
59. Russell RR, 3rd, Li J, Coven DL, et al AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004; 114: 495-503.
60. Xing Y, Musi N, Fujii N, et al Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem. 2003; 278: 28372-7.
61. Li J, Miller EJ, Ninomiya-Tsuji J, et al AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res. 2005; 97: 872-9.
62. Sukhodub A, Jovanovic S, Du Q, et al AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels. J Cell Physiol. 2007; 210: 224-36.
63. Ahmad F, Arad M, Musi N, et al Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. Circulation. 2005; 112: 3140-8.
64. 2-sensing cells J Biol Chem. 2005; 280: 41504-11.
65. Rubin LJ, Magliola L, Feng X, et al Metabolic activation of AMP kinase in vascular smooth muscle. J Appl Physiol. 2005; 98: 296-306.
66. Davis BJ, Xie Z, Viollet B, et al Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes. 2006; 55: 496-505.
67. Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res. 2007; 75: 247-60.
68. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006; 113: 1708-14.
69. Chen ZP, Mitchelhill KI, Michell BJ, et al AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 1999; 443: 285-9.
70. Hu Z, Chen J, Wei Q, et al Bidirectional actions of hydrogen peroxide on endothelial nitric-oxide synthase phosphorylation and function: co-commitment and interplay of Akt and AMPK. J Biol Chem. 2008; 283: 25256-63.
71. Chen Z, Peng I-C, Sun W, et al AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res. 2009; 104: 496-505.
72. Xu Q, Hao X, Yang Q, et al Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. Biochem Biophys Res Commun. 2009; 388: 389-94.
73. Zou M-H, Kirkpatrick SS, Davis BJ, et al Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem. 2004; 279: 43940-51.
74. Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes. 2002; 51: 159-67.
75. Murakami H, Murakami R, Kambe F, et al Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC. Biochem Biophys Res Commun. 2006; 341: 973-8.
76. Okayasu T, Tomizawa A, Suzuki K, et al PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation. Life Sci. 2008; 82: 884-91.
77. Hattori Y, Suzuki K, Hattori S, et al Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension. 2006; 47: 1183-8.
78. Xie Z, Dong Y, Scholz R, et al Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation. 2008; 117: 952-62.
79. Xie Z, Dong Y, Zhang J, et al Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol. 2009; 29: 3582-96.
80. Ceolotto G, Gallo A, Papparella I, et al Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol. 2007; 27: 2627-33.
81. Boyle JG, Logan PJ, Ewart M-A, et al Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase. J Biol Chem. 2008; 283: 11210-7.
82. Deng G, Long Y, Yu Y-R, et al Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway. Int J Obes (Lond). 2010; 34: 165-71.
83. Tomizawa A, Hattori Y, Kasai K. Induction of gene expression in response to globular adiponectin in vascular endothelial cells. Life Sci. 2009; 85: 457-61.
84. Chandrasekar B, Boylston WH, Venkatachalam K, et al Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression. J Biol Chem. 2008; 283: 24889-98.
85. Xu X, Jhun BS, Ha CH, et al Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 2008; 149: 4183-92.
86. Procopio C, Andreozzi F, Laratta E, et al Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. Endocrinology. 2009; 150: 3584-93.
87. Goirand F, Solar M, Athea Y, et al Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. J Physiol. 2007; 581: 1163-71.
88. Horman S, Morel N, Vertommen D, et al AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J Biol Chem. 2008; 283: 18505-12.
89. Robertson TP, Mustard KJW, Lewis TH, et al AMP-activated protein kinase and hypoxic pulmonary vasoconstriction. Eur J Pharmacol. 2008; 595: 39-43.
90. Barman SA, Zhu S, White RE. Hypoxia modulates cyclic AMP activation of BkCa channels in rat pulmonary arterial smooth muscle. Lung. 2005; 183: 353-61.
91. Nagata D, Takeda R, Sata M, et al AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation. 2004; 110: 444-51.
92. Igata M, Motoshima H, Tsuruzoe K, et al Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res. 2005; 97: 837-44.
93. Liang K-W, Yin S-C, Ting C-T, et al Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. Eur J Pharmacol. 2008; 590: 343-54.
94. Kim S-Y, Jeoung NH, Oh CJ, et al Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Circ Res. 2009; 104: 842-50.
95. Kato K, Ogura T, Kishimoto A, et al Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene. 2002; 21: 6082-90.
96. Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem. 2003; 278: 31000-6.
97. Ouchi N, Kobayashi H, Kihara S, et al Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2004; 279: 1304-9.
98. Yun H, Lee M, Kim S-S, et al Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem. 2005; 280: 9963-72.
99. Ouchi N, Shibata R, Walsh K. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ Res. 2005; 96: 838-46.
100. Levine YC, Li GK, Michel T. Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK → Rac1 → Akt → endothelial nitric-oxide synthase pathway. J Biol Chem. 2007; 282: 20351-64.
101. Webler AC, Michaelis UR, Popp R, et al Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. Am J Physiol Cell Physiol. 2008; 295: C1292-301.
102. Phoenix KN, Vumbaca F, Claffey KP. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Tr. 2009; 113: 101-11.
103. Zwetsloot KA, Westerkamp LM, Holmes BF, et al AMPK regulates basal skeletal muscle capillarization and VEGF expression, but is not necessary for the angiogenic response to exercise. J Physiol. 2008; 586: 6021-35.
104. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005; 111: 3481-8.
105. Igata M, Motoshima H, Tsuruzoe K, et al Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res. 2005; 97: 837-44.
106. Zang M, Xu S, Maitland-Toolan KA, et al Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes. 2006; 55: 2180-91.
107. Devaraj S, Torok N, Dasu MR, et al Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008; 28: 1368-74.
108. Motobayashi Y, Izawa-Ishizawa Y, Ishizawa K, et al Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells. Hypertens Res. 2009; 32: 188-93.
109. Colombo SL, Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J. 2009; 421: 163-9.
110. Dong Y, Zhang M, Liang B, et al Reduction of AMP-activated protein kinase {alpha}2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation. 2010; 121: 792-803.
111. Ishii N, Matsumura T, Kinoshita H, et al Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation. J Biol Chem. 2009; 284: 34561-9.
112. Kurdi M, Cerutti C, Randon J, et al Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: identification of target genes for renin. J Renin Angiotensin Aldosterone Syst. 2004; 5: 72-8.
113. Zhou M-S, Schulman IH, Raij L. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. J Hypertens. 2010; 28: 527-35.
114. Rodríguez A, Catalán V, Becerril S, et al Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats. Life Sci. 2008; 83: 540-9.
115. Zhang P, Hu X, Xu X, et al AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Hypertension. 2008; 52: 918-24.
116. Hattori Y, Akimoto K, Nishikimi T, et al Activation of AMP-activated protein kinase enhances angiotensin II-induced proliferation in cardiac fibroblasts. Hypertension. 2006; 47: 265-70.
117. Kuramoto N, Wilkins ME, Fairfax BP, et al Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase. Neuron. 2007; 53: 233-47.
118. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA. 2007; 104: 7217-22.
119. Culmsee C, Monnig J, Kemp BE, et al AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci. 2001; 17: 45-58.
120. McCullough LD, Zeng Z, Li H, et al Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem. 2005; 280: 20493-502.
121. Li J, Zeng Z, Viollet B, et al Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke. 2007; 38: 2992-9.
122. Li J, McCullough LD. Effects of AMP-activated protein kinase in cerebral ischemia. J Cerebr Blood F Met. 2010; 30: 480-92.
123. Nagata D, Hirata Y. The role of AMP-activated protein kinase in the cardiovascular system. Hypertens Res. 2010; 33: 22-8.
124. Cool B, Zinker B, Chiou W, et al Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 2006; 3: 403-16.